Picture Berlin Partner Top News from HealthCapital Berlin-Brandenburg 650x100px
Organisation › Details

AstraZeneca (Group)

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. *


Period Start 1999-04-05 merged
  Predecessor Zeneca (Group)
Product Industry pharmaceutical
Persons Person Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO)
  Person 2 Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK)
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street 1 Francis Crick Avenue
Cambridge Biomedical Campus
  City CB2 0AA Cambridge, Cambridgeshire
    Address record changed: 2022-11-29
Basic data Employees I: 50,001 to 100,0 (2019-12-31)
  Currency USD
  Annual sales 24,384,000,000 (revenue, total, consolidated (2019) 2019-12-31)
  Profit 1,227,000,000 (2019-12-31)
  Cash 5,369,000,000 (2019-12-31)
    * Document for »About Section«: AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy".
Record changed: 2023-08-22


Picture Berlin Partner Voices from HealthCapital Charpentier 650x200px

More documents for AstraZeneca (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Biotech Showcase 2024 San Francisco 650x300px

» top